High Blood Pressure 2016: Why Prevention and Control Are Urgent and Important. The World Hypertension League, International Society of Hypertension, World Stroke Organization, International Diabetes Foundation, International Council of Cardiovascular Prevention and Rehabilitation, International Society of Nephrology

Journal of Clinical Hypertension

Volumn 18, Issue 8, 2016, Pages 714-717

  Campbell, Norm R ^a   Khalsa, Tej ^b   Lackland, Daniel T ^d   Niebylski, Mark L ^d   Nilsson, Peter M ^d   Redburn, Kimbree A ^d   Orias, Marcelo ^d   Zhang, Xin Hua ^d   Burrell, Louise ^d   Horiuchi, Masatsugu ^d   Poulter, Neil R ^d   Prabhakaran, Dorairaj ^d   Ramirez, Agustin J ^d   Schiffrin, Ernesto L ^d   Touyz, Rhian M ^d   Wang, Ji Guang ^d   Weber, Michael A ^d  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c WHL   (United States)

^d c/o Kenes International ^*

^e IDF   (Belgium)

^f YORK UNIVERSITY   (Canada)

^g ISN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAUSE OF DEATH; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DISABILITY; ENVIRONMENTAL FACTOR; EPIDEMIC; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INVESTMENT; LIFESTYLE; MEDICAL SOCIETY; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY ADJUSTED LIFE YEAR; RISK FACTOR; WELLBEING; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; COMPLICATION; DIABETES MELLITUS; NEPHROLOGY;

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIABETES MELLITUS; HUMANS; HYPERTENSION; NEPHROLOGY; STROKE;

EID: 84978252508     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12840     Document Type: Note

References (50)

1. Institute for Health Metrics and Evaluation, 2015 University of Washington. http://vizhub.healthdata.org/gbd-compare/. Accessed December 22, 2015.
2. Campbell NR, Lackland DT, Niebylski ML; World Hypertension League Committee; International Society of Hypertension Executive Committee. High blood pressure: why prevention and control are urgent and important: a 2014 fact sheet from the World Hypertension League and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014;16:551–553 doi: 10.1111/jch.12372. Epub 2014 Jul 17.
3. World Health Organization. A Global Brief on Hypertension: Silent Killer, Global Public Health Crisis. World Health Day 2013. Geneva, Switzerland: World Health Organization; 2013.
4. Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557–1562.
5. Udani S, Lazich I, Bakris GL. Epidemiology of hypertensive kidney disease. Nat Rev Nephrol. 2011;7:11–21.
6. Levi MN, Macquin-Mavier I, Tropeano AI, et al. Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. J Hypertens. 2013;31:1073–1082.
7. Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367:1066–1074.
8. Seely EW, Maxwell C. Cardiology patient page. Chronic hypertension in pregnancy. Circulation. 2007;115:e188–e190.
9. Chen G, McAlister FA, Walker RL, et al. Cardiovascular outcomes in Framingham participants with diabetes: the importance of blood pressure. Hypertension. 2011;57:891–897.
10. Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016;387:957–967.
11. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men. JAMA. 2002;287:1003–1010.
12. Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513–1518.
13. Gaziano TA, Bitton A, Anand S, Weinstein MC. The global cost of nonoptimal blood pressure. J Hypertens. 2009;27:1472–1477.
14. Committee on Public Health Priorities to Reduce and Control Hypertension in the U.S. Population, Institute of Medicine of the National Academies. A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension. Washington, DC: National Academies Press; 2010.
15. Nissinen A, Pietinen P, Tuomilehto J, et al. Predictors of blood pressure change in a series of controlled dietary intervention studies. J Hum Hypertens. 1987;1:167–173.
16. Perkovic V, Huxley R, Wu Y, et al. The burden of blood pressure-related disease: a neglected priority for global health. Hypertension. 2007;50:991–997.
17. Ibrahim MM, Damasceno A. Hypertension in developing countries. Lancet. 2012;380:611–619.
18. World Health Organization. WHO Global Status Report on Noncommunicable Diseases 2010. Geneva, Switzerland: WHO Press, World Health Organization; 2011.
19. Mozaffarian D, Afshin A, Benowitz NL, et al. Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association. Circulation. 2012;126:1514–1563.
20. Wilson JF. Can disease prevention save health reform? Ann Intern Med. 2009;151:145–148.
21. World Health Organization. Diet, Nutrition and the Prevention of Chronic Diseases: Report of a Joint WHO/FAO Epert Consultantion. Geneva, Switzerland: World Health Organization; 2003. Report No.: 1.
22. World Health Organization. WHO Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–2020. Geneva, Switzerland: WHO Press, World Health Organization; 2013.
23. United Nations General Assembly. Note by the Secretary-General Transmitting the Report of the Director-General of the World Health Organization on the Prevention and Control of Non-communicable Diseases. New York, USA: Department for General Assembly and Conference Management; 2013 Dec 10.
24. National Clinical Guideline Centre. Hypertension. Clinical management of primary hypertension in adults. London (UK): National Institute for Health and Clinical Excellence (NICE); 2011 Aug. 36 p. (Clinical guideline; no. 127).
25. Whitworth JA. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983–1992.
26. Xie X, Atkins E, Lv J, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet 2016;387:435–443.
27. Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103–2116.
28. Kotchen TA. The search for strategies to control hypertension. Circulation. 2010;122:1141–1143.
29. Campbell NRC, Niebylski M. Prevention and control of hypertension: developing a global agenda. Curr Opin Cardiol. 2014;29:324–330.
30. Campbell NR, Lackland DT, Lisheng L, et al. Using the global burden of disease study to assist development of nation-specific fact sheets to promote prevention and control of hypertension and reduction in dietary salt: a resource from the World Hypertension League. J Clin Hypertens (Greenwich). 2015;17:165–167.
31. Campbell NR, Bovet P, Schutte AE, et al. High blood pressure in sub-Saharan Africa: why prevention, detection, and control are urgent and important. J Clin Hypertens (Greenwich). 2015;17:663–667.
32. Campbell NR, Lackland DT, Lisheng L, et al. The World Hypertension League challenges hypertension and cardiovascular organizations to develop strategic plans for the prevention and control of hypertension. J Clin Hypertens (Greenwich). 2015;17:325–327.
33. Campbell NR, Redburn KA, Niebylski ML, et al. Restructuring hypertension congresses and scientific meetings for improved hypertension prevention and control. J Clin Hypertens (Greenwich). 2016;18:169–171.
34. Campbell NR, Appel LJ, Cappuccio FP, et al. A call for quality research on salt intake and health: from the World Hypertension League and supporting organizations. J Clin Hypertens (Greenwich). 2014;16:469–471.
35. Campbell NR, Lackland DT, MacGregor GA. Dietary sodium: a perspective on recent sodium evidence–its interpretation and controversies. J Clin Hypertens (Greenwich). 2013;15:765–768.
36. Campbell NR, Lackland DT, Niebylski ML. 2014 Dietary salt fact sheet of the World Hypertension League, International Society of Hypertension, Pan American Health Organization technical advisory group on cardiovascular disease prevention through dietary salt reduction, the World Health Organization collaborating centre on population salt reduction, and World Action on Salt & Health. J Clin Hypertens (Greenwich). 2015;17:7–9.
37. Johnson C, Raj TS, Trudeau L, et al. The science of salt: a systematic review of clinical salt studies 2013 to 2014. J Clin Hypertens (Greenwich). 2015;17:401–411.
38. Campbell NR, Lackland DT, Niebylski ML, Nilsson PM. Is reducing dietary sodium controversial? Is it the conduct of studies with flawed research methods that is controversial? A perspective from the World Hypertension League executive. J Clin Hypertens (Greenwich). 2015;17:85–86.
39. Campbell NR, Correa-Rotter R, Cappuccio FP, et al. Proposed nomenclature for salt intake and for reductions in dietary salt. J Clin Hypertens (Greenwich). 2015;17:247–251.
40. Campbell N, Lackland D, Chockalingam A, et al. The World Hypertension League and International Society of Hypertension call on governments, nongovernmental organizations, and the food industry to work to reduce dietary sodium. J Clin Hypertens (Greenwich). 2014;16:99–100.
41. Mangat BK, Campbell N, Mohan S, et al. Resources for blood pressure screening programs in low resource settings: a guide from the world hypertension league. J Clin Hypertens (Greenwich). 2015;17:418–420.
42. Campbell NR, Berbari AE, Cloutier L, et al. Policy statement of the World Hypertension League on noninvasive blood pressure measurement devices and blood pressure measurement in the clinical or community setting. J Clin Hypertens (Greenwich). 2014;16:320–322.
43. Campbell NR, Niebylski ML, Redburn K, et al. World Hypertension League position on public use of blood pressure kiosks. J Clin Hypertens (Greenwich). 2015;17:913.
44. Campbell NRC, Gelfer M, Stergiou GS, et al. A call to regulate manufacture and marketing of blood pressure devices and cuffs. A position statement from the World Hypertension League, International Society of Hypertension and supporting hypertension organizations. J Clin Hypertens (Greenwich). 2016;18:378–380.
45. World Health Organization. WHO Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care in Low-Resource Settings. Geneva, Switzerland: World Health Organization; 2010.
46. Zhang XH, Lisheng L, Campbell NR, et al. Implementation of World Health Organization Package of Essential Noncommunicable disease interventions (WHO PEN) for primary health care in low-resource settings: a policy statement from the World Hypertension League. J Clin Hypertens (Greenwich). 2016;18:5–6.
47. Khatib R, McKee M, Shannon H, et al. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet. 2016;2:61–69.
48. Gee ME, Campbell N, Sarrafzadegan N, et al. Standards for the uniform reporting of hypertension in adults using population survey data: recommendations from the World Hypertension League expert committee. J Clin Hypertens (Greenwich). 2014;16:773–781.
49. Redburn KA, Niebylski ML. Excellence and notable achievement awards from the World Hypertension League: a call for 2015 nominations. J Clin Hypertens (Greenwich). 2014;16:928–929.
50. Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014;16:14–26.